These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 23990527)

  • 1. Varenicline may reduce negative effect while aiding smoking cessation.
    Hays JT
    Evid Based Med; 2014 Feb; 19(1):23. PubMed ID: 23990527
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal.
    Cinciripini PM; Robinson JD; Karam-Hage M; Minnix JA; Lam C; Versace F; Brown VL; Engelmann JM; Wetter DW
    JAMA Psychiatry; 2013 May; 70(5):522-33. PubMed ID: 23536105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking cessation interventions: a primer for physicians: Comment on "Use of varenicline for 4 weeks before quitting smoking".
    Simon JA
    Arch Intern Med; 2011 Apr; 171(8):777-8. PubMed ID: 21518947
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of coadministration of varenicline, bupropion, and serotonin reuptake inhibitors in a smoking cessation program in the real-life setting.
    Issa JS; Abe TO; Moura S; Santos PC; Pereira AC
    Nicotine Tob Res; 2013 Jun; 15(6):1146-50. PubMed ID: 23128516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the success of treating tobacco smokers.
    Rigotti NA
    JAMA Intern Med; 2015 Feb; 175(2):272-3. PubMed ID: 25545347
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current and future medical drugs for smoking cessation].
    Kusma B; Mache S; Deissenrieder F; Quarcoo D; Welte T; Groneberg D
    Laryngorhinootologie; 2009 Jun; 88(6):410-9; quiz 420-2. PubMed ID: 19504411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medical therapy for smoking cessation].
    Zeller A
    Ther Umsch; 2010 Aug; 67(8):419-25. PubMed ID: 20687045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers.
    Linden K; Jormanainen V; Linna M; Sintonen H; Wilson K; Kotomäki T
    Curr Med Res Opin; 2010 Mar; 26(3):549-60. PubMed ID: 20050814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Specific program for smoking cessation: thus your patients become nonsmokers].
    Hering T
    MMW Fortschr Med; 2008 Nov; 150(46):42-3. PubMed ID: 19133359
    [No Abstract]   [Full Text] [Related]  

  • 10. Did the introduction of varenicline in England substitute for or add to the use of other smoking cessation medications?
    Kotz D; Fidler JA; West R
    Nicotine Tob Res; 2011 Sep; 13(9):793-9. PubMed ID: 21543548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in health-related quality of life with smoking cessation treatment.
    Hays JT; Croghan IT; Baker CL; Cappelleri JC; Bushmakin AG
    Eur J Public Health; 2012 Apr; 22(2):224-9. PubMed ID: 20884658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking cessation-recent advances.
    McNeil JJ; Piccenna L; Ioannides-Demos LL
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):359-67. PubMed ID: 20602163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular adverse events associated with smoking-cessation pharmacotherapies.
    Sharma A; Thakar S; Lavie CJ; Garg J; Krishnamoorthy P; Sochor O; Arbab-Zadeh A; Lichstein E
    Curr Cardiol Rep; 2015 Jan; 17(1):554. PubMed ID: 25410148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of varenicline tartrate and counseling versus counseling alone for smoking cessation: a randomized controlled trial for inpatients (STOP study).
    Carson KV; Smith BJ; Brinn MP; Peters MJ; Fitridge R; Koblar SA; Jannes J; Singh K; Veale AJ; Goldsworthy S; Litt J; Edwards D; Hnin KM; Esterman AJ
    Nicotine Tob Res; 2014 Nov; 16(11):1495-502. PubMed ID: 25031315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking cessation: an overview of treatment options with a focus on varenicline.
    Stack NM
    Pharmacotherapy; 2007 Nov; 27(11):1550-7. PubMed ID: 17963463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to varenicline in the COMPASS smoking cessation intervention trial.
    Catz SL; Jack LM; McClure JB; Javitz HS; Deprey M; Zbikowski SM; McAfee T; Richards J; Swan GE
    Nicotine Tob Res; 2011 May; 13(5):361-8. PubMed ID: 21350041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost-effectiveness of an extended course (12+12 weeks) of varenicline compared with other available smoking cessation strategies in the United States: an extension and update to the BENESCO model.
    Knight C; Howard P; Baker CL; Marton JP
    Value Health; 2010; 13(2):209-14. PubMed ID: 19912599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeating the same mistake.
    Prescrire Int; 2014 Sep; 23(152):200. PubMed ID: 25325112
    [No Abstract]   [Full Text] [Related]  

  • 19. Breaking away from a narrow prescribing protocol for medicinal nicotine.
    Stapleton JA
    Addiction; 2008 Apr; 103(4):564-5. PubMed ID: 18339102
    [No Abstract]   [Full Text] [Related]  

  • 20. [Varenicline--a new chance for smokers?].
    Goniewicz ML; Koszowski B; Czogała J; Sobczak A
    Przegl Lek; 2007; 64(10):899-902. PubMed ID: 18409337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.